Literature DB >> 2114993

A circadian rhythm of serum osteocalcin levels in postmenopausal osteoporosis.

P Pietschmann1, H Resch, W Woloszczuk, R Willvonseder.   

Abstract

The serum levels of osteocalcin, a 49 amino acid bone matrix protein, have been found to be a specific biochemical parameter of bone formation. The aim of our study was to assess the variability of serum osteocalcin and parathyroid hormone levels in postmenopausal osteoporosis. In 16 patients with postmenopausal osteoporosis, serum levels of osteocalcin and parathyroid hormone were determined in 4-hourly intervals by radioimmunoassay. Whereas the serum parathyroid hormone levels were similar throughout the day, the serum osteocalcin levels showed a circadian rhythm, with lowest levels in the morning and maximal levels during the night. These findings might suggest a circadian variation of bone formation in patients with postmenopausal osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114993     DOI: 10.1111/j.1365-2362.1990.tb01861.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  4 in total

1.  Circadian rhythm in type I collagen formation in postmenopausal women with and without osteopenia.

Authors:  B J Pedersen; A Schlemmer; C Rosenquist; C Hassager; C Christiansen
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

2.  Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission.

Authors:  C M Bastos; I M Araújo; M H Nogueira-Barbosa; C E G Salmon; F J A de Paula; L E A Troncon
Journal:  Osteoporos Int       Date:  2017-04-12       Impact factor: 4.507

3.  MicroRNA-433 Dampens Glucocorticoid Receptor Signaling, Impacting Circadian Rhythm and Osteoblastic Gene Expression.

Authors:  Spenser S Smith; Neha S Dole; Tiziana Franceschetti; Henry C Hrdlicka; Anne M Delany
Journal:  J Biol Chem       Date:  2016-08-22       Impact factor: 5.157

4.  The role of enteric hormone GLP-2 in the response of bone markers to a mixed meal in postmenopausal women with type 2 diabetes mellitus.

Authors:  Laura S Girão Lopes; Rubens Prado Schwartz; Bruno Ferraz-de-Souza; Maria Elizabeth Rossi da Silva; Pedro Henrique Silveira Corrêa; Márcia Nery
Journal:  Diabetol Metab Syndr       Date:  2015-02-27       Impact factor: 3.320

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.